Breaking News
July 23, 2018 - No Outcome Differences Based on Anesthesia Team Make-Up
July 23, 2018 - Getting to the heart of congenital cardiac defects
July 23, 2018 - Healthy behaviors are not effective in preventing gestational diabetes in obese women
July 23, 2018 - Top of Teachers’ To-Do List: Focus on the Positives
July 23, 2018 - LDL quality is a novel, modifiable cardiovascular risk marker
July 22, 2018 - Researchers identify enzyme as potential new drug target for blood disorders
July 22, 2018 - Research shows that neurons can encode more than one signal at a time
July 22, 2018 - Exposure to secondhand smoke increases the risk of stillbirth
July 22, 2018 - Skin conditions by the numbers
July 22, 2018 - Brain tumour chemotherapy now available to even more NHS patients
July 22, 2018 - Researchers find mugwort pollen as major source of airborne endotoxins
July 22, 2018 - Occupational safety and health at workplace
July 22, 2018 - Pfizer And Lilly Announce Positive Top-Line Results From Phase 3 Trial Of Tanezumab For The Treatment Of Osteoarthritis (OA) Pain
July 22, 2018 - Early supper associated with lower risk of breast and prostate cancer
July 22, 2018 - Survey results identify major inequalities in acute stroke treatment across Europe
July 22, 2018 - Researchers discover promising treatment for genetic form of autism spectrum disorder
July 22, 2018 - Prenatal Depression More Common in Young Moms Today
July 22, 2018 - What helps adults with autism get and keep a job?
July 22, 2018 - Pediatric NEXUS Head CT DI guides selective imaging decisions in blunt trauma patients
July 22, 2018 - Novel tool predicts genes that cause disease due to production of truncated proteins
July 22, 2018 - AHA: Vaping Tied to Blood Clots — in Mice
July 22, 2018 - Study finds therapy dogs effective in reducing symptoms of ADHD
July 22, 2018 - Scientists find reason why malarial parasites are faster than immune cells
July 22, 2018 - Researchers gain more insight into how FUS protein causes ALS and FTLD
July 22, 2018 - Frequency of joint replacements halved in rheumatoid arthritis patients between 1997-2010
July 22, 2018 - QUT researcher highlights growing impact of non-prescription antibiotics supply in pharmacies
July 22, 2018 - UK health communication researcher seeks solutions for disposing leftover medicine
July 22, 2018 - Pfizer Initiates Pivotal Phase 3 Program for Investigational Hemophilia B Gene Therapy Fidanacogene Elaparvovec
July 22, 2018 - Mutation discovered to protect against Alzheimer’s disease in mice
July 22, 2018 - Researchers reveal how patients in urban areas develop multiple, long-term conditions
July 22, 2018 - Replacing conventional cancer treatment with complementary therapy linked to increased risk of death
July 22, 2018 - Study uncovers molecular key for delaying progression of multiple sclerosis
July 22, 2018 - Availability of athletic trainer in high school reduces injury rates in girls’ sports, shows study
July 22, 2018 - FDA Approves Krintafel (tafenoquine) for the Radical Cure of Plasmodium vivax Malaria
July 22, 2018 - Novel nuclear medicine probe will help assess new drugs for neurodegenerative diseases
July 22, 2018 - Physical activity even during exposure to air pollution can reduce risk of heart attack
July 22, 2018 - Scientists discover protein regulator of myelin production
July 22, 2018 - Sleep disturbances associated with higher dementia risk
July 22, 2018 - Scientists move one step further in developing eye drops to treat age-related macular degeneration
July 22, 2018 - Five-Year Stroke Rates Lower After PCI Versus CABG
July 21, 2018 - Alopecia areata – Genetics Home Reference
July 21, 2018 - Study identifies overdose risk factors in youth with substance use disorders
July 21, 2018 - Drug in clinical trials for Parkinson’s disease offers hope for treating heart failure
July 21, 2018 - Coupling free malaria tests with diagnosis-dependent vouchers can improve rational use of ACTs
July 21, 2018 - Sweetness depends on molecular interactions between specific sugars and water in saliva
July 21, 2018 - Muscle fitness is strongly associated with improved rate of ageing in the brain
July 21, 2018 - Resetting E-Prescriptions for Opioids Helps Curb Use: Study
July 21, 2018 - Overuse of antibiotics not what the doctor ordered
July 21, 2018 - Bundled-payment system did not lower costs for serious medical conditions, shows study
July 21, 2018 - Therapy dogs found to be effective in reducing ADHD symptoms in children
July 21, 2018 - Could rotating multiple therapists better treat PTSD patients?
July 21, 2018 - Binge drinking impairs working memory in adolescent brain
July 21, 2018 - Dying at home could be beneficial for terminally ill cancer patients and their relatives
July 21, 2018 - Researchers identify subtypes of retinal ganglion cells using single-cell RNA sequencing
July 21, 2018 - Study uncovers opportunities to reduce death by suicide among cancer patients
July 21, 2018 - Genetic sequencing reveals new clues to aggressiveness of prostate cancer
July 21, 2018 - BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia
July 21, 2018 - First major study comparing robotic to open surgery published in The Lancet
July 21, 2018 - ADHD medications may fail to improve cognition in healthy college students, study shows
July 21, 2018 - Intervention program that includes a personalized app could benefit teens with suicidal thoughts
July 21, 2018 - Researchers identify new compound that protects against neurodegeneration
July 21, 2018 - Gene therapy may hold potential to treat people with spinal cord injuries
July 21, 2018 - FDA Approves Nivestym (filgrastim-aafi), a Biosimilar to Neupogen
July 21, 2018 - Surgeons have substantial impact on genetic testing in breast cancer patients who need it
July 21, 2018 - Species diversity can have positive and negative impacts on disease transmission
July 21, 2018 - Genome research suggests presence of enteric fever in medieval Europe
July 21, 2018 - Risk of Sensory Deficits Drops With Rising Gestational Age
July 21, 2018 - Mum’s sleep matters—the effect of sleep on an unborn baby
July 21, 2018 - UC San Diego researchers awarded two grants for investigating stem cell-based therapies
July 21, 2018 - Cellular ‘garbage disposal’ may actually work on some of the proteins to neuronal development
July 21, 2018 - More Pregnant Women Having Heart Attacks
July 21, 2018 - Acne Breakouts | NIH News in Health
July 21, 2018 - Change health messaging to focus on potential impact to help stop the next pandemic
July 21, 2018 - Frailty associated with poor survival rates in young heart patients
July 21, 2018 - New discovery could save millions of lives from fatal fungal infections
July 21, 2018 - OBD presents latest data on the use of EpiSwitch™ in predicting patient response to immunotherapy and identifying lymphoma subtypes
July 21, 2018 - Childhood adversity increases susceptibility to addiction via immune response
July 21, 2018 - Scientists identify potential target for the treatment of binge eating
July 21, 2018 - Whole-brain LIPUS therapy improves cognitive dysfunction in mice simulating dementia, Alzheimer’s
July 21, 2018 - Digital media use raising risk of ADHD symptoms among the young
Dear drug using up Medicare expenditures with out proof of better efficacy

Dear drug using up Medicare expenditures with out proof of better efficacy

image_pdfDownload PDFimage_print

Medicare spent greater than $1 billion over a five-year duration on a high-priced drug that has no longer been confirmed more practical for a number of inflammatory prerequisites than a lot more economical corticosteroids, analysis by means of the OHSU/OSU School of Pharmacy presentations.

The research additionally signifies relatively small staff of “common prescribers” mix to put in writing prescriptions that result in the majority of Medicare’s expenditures at the drug, repository adrenocorticotropin, or ACTH.

In 2015 on my own, Medicare spending crowned $500 million at the drug, the price of which has soared to $36,000 in line with process treatment.

Recognized by means of the industry identify H.P. Acthar Gel, steadily shortened to simply Acthar, the drug’s number one use is to regard uncommon epileptic spasms in kids beneath age 2.

“The drug has an enchanting again tale,” stated Dan Hartung, lead creator on a analysis letter that used to be revealed as of late in JAMA Inside Medication. “It is a rather outdated drug, first authorized in 1952, previous to most of the FDA laws about scientific efficacy. The bar for what constitutes authorized indications used to be a lot other then, a lot decrease; it has many indications that got here ahead of the present laws have been set in stone within the 1960s.”

The drug, categorized as a “biologic,” used to be to start with authorized for a huge vary of corticosteroid-responsive inflammatory prerequisites.

“It is a hormone produced within the human frame that alerts the discharge of steroids,” Hartung stated. “It does the similar activity as cheap corticosteroids. And it in point of fact wasn’t a lot on somebody’s radar till 2007.”

Questcor Prescribed drugs bought the rights to the in large part forgotten Acthar in 2001 for $100,000 and started often elevating Acthar’s value. In 2007 Questcor greater the cost of the drug, which as soon as bought for $40 for a vial, or process treatment, from $1,650 to $23,000 in a single day.

Questcor, got by means of Mallinckrodt Prescribed drugs in 2017, markets the drug aggressively for slightly not unusual prerequisites comparable to rheumatoid arthritis, a couple of sclerosis and nephrotic syndrome, Hartung stated. The Meals and Drug Management authorized Acthar for the ones sorts of prerequisites a long time in the past when necessities have been much less strict; no scientific trials have been required.

“There are a selection of FDA-approved indications that lack numerous proof that Acthar is even efficient, let on my own higher than reasonably priced corticosteroids,” Hartung stated. “And what lets in for this sort of pricing is that it is a rather complicated molecule and no competition can precisely replica it; they have got a monopoly in this specific molecule.”

In 2015, Acthar generated gross earnings of about $1 billion – greater than part of which got here from Medicare, and far of the remainder coming from Medicaid, Hartung stated, which means public expenditures most probably accounted for just about all the gross sales.

Hartung and the opposite collaborators discovered Medicare spending at the drug greater tenfold and totaled $1.three billion from 2011 to 2015.

In 2014, a complete of one,621 prescribers have been liable for $391.2 million in Acthar spending; amongst the ones, 203 common prescribers – 94 rheumatologists, 55 neurologists and 54 nephrologists, each and every with greater than 10 prescriptions – accounted for $165 million of the entire.

“And on the whole those physicians are prescribing about the similar collection of different medicine in comparison to their peer uniqueness teams, so we suspect they aren’t treating extra significantly unwell sufferers,” Hartung stated. “Mallinckrodt is in point of fact aggressively advertising and marketing in ways in which perhaps topic prescribers to conflicts of pastime. From the payer facet, there may be in point of fact little that little justifies this drug and its exorbitant price over a lot inexpensive choices. If Medicare have been to take a company stand on reimbursements, this would not be going down.”

Discover additional:
Mallinckrodt purchasing Questcor for approximately $five.6B (Replace)

Additional information:
JAMA Inside Medication (2017). DOI: 10.11001/jamainternmed.2017.3631

Magazine reference:
JAMA Inside Medication

Equipped by means of:
Oregon State College

Tagged with:

About author

Related Articles